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Abstract 
Background 
Patients with advanced heart failure have seen decreased mortality and improved 
quality of life due to mechanical circulatory support with left ventricular assist 
devices (LVAD). Regardless of such outcomes, many complications still exist and 
remain a significant cause of morbidity and mortality. Our purpose is to study the 
prevalence, clinical course, and outcomes specifically of patients with LVAD 
driveline (DL) fractures. 
Methods 
This single-center, retrospective review included all patients at our institution who 
had continuous flow LVADs and experienced DL fracture/injury from January 2012 
- December 2015. 
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Results 
Thirteen of 110 LVAD patients (11.8%) had DL fractures (Table 1). Time from 
implant to time of fracture was 23+/-16.5 months. The majority of fractures were 
external (62%), due to trauma (i.e. cut during dressing change). Internal injury, 
proximal to the cutaneous exit site, occurred in 38% of patients, usually due to 
unknown causes. Only one patient (7.6%) survived on LVAD support. One 
survived LVAD explant, two underwent pump exchange, and four others 
underwent heart transplantation. The remaining 5 expired. All patients with 
untreated internal fractures died (60%). 
Conclusions 
Driveline fracture is a rare complication of LVAD and is often lethal when it occurs. 
Only one patient in our cohort survived without the need for heart transplant, LVAD 
exchange, or explant. Internal driveline fractures portend a very high mortality. 
Driveline fracture, especially one that cannot be promptly repaired or if internal 
fracture is suspected, requires immediate pump exchange or listing for heart 
transplantation. 
Keywords:   driveline fracture, left ventricular assist device, driveline, 
complications, heart failure 
 
 
Introduction 
Despite advances in left ventricular assist device (LVAD) therapy, complications 
often negate gains in mortality benefit and can ultimately be fatal. The goal of this 
study was to investigate the clinical course, management, prevalence, and 
outcomes of “driveline (DL) fracture”. Information on DL fracture, per se, is not 
reportable to INTERMACS, hence, data regarding this complication is not 
consistently analyzed1, and medical literature on the subject is lacking. 
Methods 
All LVAD patients at our institution are included in a local registry, approved by the 
Institutional Review Board, permitting chart reviews. We retrospectively reviewed 
the records of patients who had LVAD implantation from January 2012 through 
December 2015 and analyzed all cases of DL fracture, including the data on initial 
symptoms, device alarms, fracture location, clinical course, management, and 
outcomes. Available manufacturer reports were also reviewed. 
Results 
Between January 2012 and December 2015, 110 patients were implanted with 
continuous flow LVADs at our institution, including 90 HeartMate II (HMII) and 20 
Heartware devices. Thirteen of the 110 (11.8%) experienced DL fracture, all with 
HMII LVADs. Approximately 8% of affected patients were women. 
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Mean patient age was 52 years (range 23 to 69).  
Symptoms associated with the DL fracture ranged from chest pain, to sensations 
of motor revving, to fall secondary to arrest, and were experienced by 
approximately half of the patients (46%). Device alarms were also varied and 
displayed no predictive pattern as to the type of injury; however, the “Red Heart” 
visual signal was most common (46%). Only 4 of 13 fractures (30%) could be 
detected radiographically. 
 
Between January 2012 and December 2015, 110 patients were implanted with 
continuous flow LVADs at our institution, including 90 HeartMate II (HMII) and 20 
Heartware devices. Thirteen of the 110 (11.8%) experienced DL fracture, all with 
HMII LVADs. Approximately 8% of affected patients were women. 
Mean patient age was 52 years (range 23 to 69).  
 
Symptoms associated with the DL fracture ranged from chest pain, to sensations 
of motor revving, to fall secondary to arrest, and were experienced by 
approximately half of the patients (46%). Device alarms were also varied and 
displayed no predictive pattern as to the type of injury; however, the “Red Heart” 
visual signal was most common (46%). Only 4 of 13 fractures (30%) could be 
detected radiographically. 
 
We divided the patients into 2 subgroups based on fracture location. The majority 
of DL fractures (62%) were external, due to trauma – most frequently due to 
accidental cuts during dressing changes but also included mechanisms such as 
falling off of a ladder. Internal fractures, proximal to the cutaneous exit site (below 
the skin), constituted 38% of DL injury. The cause of internal fractures was usually 
unknown. 
 
Average time from implant to fracture was 23+/-16.5 months (30.6+/-14 months for 
internal; 18+/-14 months for external). 
 
Attempts at repair of the DL fractures were dependent on each individual case. 
Most patients required placement of an ungrounded cable in order to attempt 
repair. Management ranged from fixes as simple as rescue tape to complex 
procedures such as pump exchange or ECMO. Only one patient (7.6%) survived 
on LVAD support after distal end replacement. One survived LVAD explant, two 
underwent pump exchange, and four others underwent heart transplantation. The 
remaining 5 expired. The causes of death were varied and did not correlate with 
whether or not a repair was attempted. Death occurred in 3 patients due to post-
operative complications or device malfunction after intervention, in one during 
intervention, and in another due to the patient declining intervention. Overall 
mortality of DL fracture was 38%; however, mortality was only 25% for external 
fractures and 60% for internal fractures (Table 1). 
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Table 1: Summary of individual driveline fracture cases, January 2012 – 
December 2015.  
 
 
Case 
 
Age 
 
Sex 
Cause of 
fracture 
Time to 
fracture 
(months) 
 
Symptoms 
 
Alarms 
 
Location 
 
Treatment 
 
Outcome 
 
1 
 
23 
 
M 
Hit door 
running 
 
8 
Abdominal 
pain, 
erythema 
RH / low 
speed 
 
E 
Distal end 
replaced 
 
Alive on LVAD 
 
 
2 
 
 
55 
 
 
M 
 
Cut DL 
(scissors) 
 
 
26 
 
 
 
 
 
? 
 
 
E 
Pump 
exchange 
(thrombosed 
due to 
stoppage) 
Died within 1 
month from 
complications 
during pump 
exchange surgery 
 
3 
 
46 
 
M 
 
? 
 
20 
 
 
RH / low 
flow 
 
E 
Rescue tape, 
ungrounded 
cable 
Heart transplant, 
alive 
 
4 
 
64 
 
F 
 
Cut DL 
 
<1 
 
 
RH / pump 
stop / low 
flow 
 
E 
Distal end 
repaired 
Heart transplant,  
alive 
5 54 M ? 12  
? 
E 
Distal end 
repaired 
Alive after LVAD 
explant 
 
6 
 
50 
 
M 
 
Cut DL 
 
5 
 
 
RH / low 
flow / low 
voltage 
 
E 
 
Rescue tape 
Died in 4 months 
CVA due to pump 
thromboembolism 
 
7 
 
57 
 
M 
 
? 
 
41 
Sensation of 
pump motor 
revving 
Yellow & 
red 
advisory 
 
E 
Distal end 
repaired 
Heart transplant, 
alive 
8 52 M 
Slammed 
car door 
35  
Low voltage 
E 
Rescue tape Heart transplant, 
alive 
 
9 
 
66 
 
M 
 
? 
 
49 
Chest / 
epigastric 
pain 
 
Pump stop 
 
I 
None - refused 
pump exchange 
Died within 1 
month 
 
10 
 
53 
 
M 
Fall from 
ladder 
 
12 
 
  
Pump stop / 
low flow / 
low speed 
 
I 
Pump exchange  
Alive on LVAD 
 
11 
 
33 
 
M 
Dropped 
controller 
 
24 
Subjective 
discomfort 
Low flow / 
pump off / 
DL 
disconnect 
 
I 
Pump exchange  
Alive on LVAD 
 
12 
 
69 
 
M 
 
? 
 
39 
 
Chest pain 
Audio / RH, 
low speed / 
low flow 
 
I 
Ungrounded 
cable 
Died suddenly 10 
month after the 
event 
 
13 
 
55 
 
M 
 
? 
 
26 
Fall / cardiac 
arrest 
Audio/ RH / 
green 
power 
symbol 
 
I 
 
ECMO 
Died after family 
withdrew care 
 
? = unknown, DL = driveline, RH = red heart, E= external, I = internal 
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This study sought to characterize driveline fracture and its clinical implications. The 
driveline or percutaneous lead is vulnerable as it is exposed to the environment 
and is therefore prone to infection and mechanical damage. The design of the DL 
has multiple security features to prevent fatal interruption of energy supply. 
 
The driveline consists of a single silicone cable extending from the implanted LVAD 
through the external abdominal wall and carries power to the LVAD via a system 
controller. The internal components of the driveline consist of a central strength 
member cable surrounded by six electrical conductors (3 primary and 3 backup) 
that provide power to the LVAD.  The electrical conductors are protected by a 
copper- braided shield that is covered by an inner polyurethane protective jacket, 
which is enclosed by a silicone outer jacket that encompasses the entire outer 
portion of the DL (Figure 1). 
 
 
 
Figure 1. Structure of the driveline (reproduced with permission of Thoratec) 
 
According to HMII LVAD malfunction data reported to the manufacturer, the 
incidence of driveline dysfunction was 9.2% compared with our incidence of 11.8%. 
As of this writing, no aggregate data regarding Heartware driveline malfunction was 
publically available. Also, similar to our findings, lead failure was mostly in the 
externalized part of the cable - 87.2%2 vs. our 62%. Minor external damage 
accounted for 76% of dysfunction, whereas major damage, such as internal and 
external wire damage and fracture, accounted for the remaining 24%2 compared to 
our 38%. Major damage can be caused by normal wear, line manipulation, 
inattention to care and maintenance, and traumatic damage. Younger age, female 
sex, and larger body surface area were identified as factors associated with DL 
damage2. 
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Although manufacturers have been able to decrease incidence of mechanical 
complications with design improvements2, the contribution of human error cannot 
be completely eliminated. A previously published series reported four cases of 
external DL fracture, all due to patient-related lead twisting or kinking. In all cases, 
the device was exchanged3. Data from more than 1,000 patients participating in 
both HMII bridge- to-transplant and destination therapy trials show the most 
common reason for LVAD replacement is DL damage, accounting for 47% of all 
pump replacements and occurring in 3% of implanted HMII devices4. Device 
exchange is relatively safe with a 30-day surgical mortality of 6.5%4. 
 
Although driveline fracture is rare, it is often lethal. As evidenced by the data, only 
one patient in our cohort (7.6%) survived without the need for major intervention 
such as heart transplantation, LVAD exchange, or device explant. Furthermore, 
internal driveline fractures portended a very high mortality. This is likely due to two 
factors: access to the injury site and appropriateness of the patient to undergo 
surgery, which in itself carries a morbidity and mortality risk. External fractures 
carried a 2.5-fold lower mortality as the injury could be physically accessed and 
repaired, despite a patient’s clinical status which may have precluded them from 
surgery. 
 
We propose that patients who present with an internal DL fracture or one that 
cannot be expeditiously repaired require immediate pump exchange or listing for 
heart transplantation. Although this was a single- center study, it is nonetheless 
evident that immediate interventions must be undertaken if the patient is to survive 
the event. 
 
Limitations 
 
The majority of our patients had HMII LVADs, which were therefore 
disproportionally represented. 
 
Conclusions 
 
Driveline fracture is a relatively common, often preventable, but frequently fatal 
complication of LVAD. Providers must educate patients regarding risks of driveline 
damage. Once diagnosed, this condition requires urgent measures such as device 
exchange or listing for transplantation. 
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